Tokyo, July 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062131) titled 'Validation study of blood biomarkers for Lewy body disease using international cohorts' on July 7.
Study Type:
Observational
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology
Condition:
Condition - Lewy body disease, including Parkinson's disease, dementia with Lewy bodies, and REM sleep behavior disorder, and related neurodegenerative disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to validate blood biomarkers, including the acetylated alpha-synuclein assay developed at QST, using existing ...